These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29399184)

  • 1. Influence of hypoxia-related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF.
    Tang W; Liu X; Qiu L; Zhao X; Huang M; Yin J; Li J; Guo W; Zhu X; Chen Z
    Oncol Lett; 2018 Jan; 15(1):1334-1342. PubMed ID: 29399184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy.
    Feng W; Liu X; Zhao X; Huang M; Guo W; Yin J; Chen Z; Zhu X
    Oncol Lett; 2018 Oct; 16(4):4489-4497. PubMed ID: 30214584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
    Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X
    PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancer.
    Wang D; Zhang X; Zhang Y; Wu Y; Guan X; Zhu W; Wang M; Qi C; Shen B
    Onco Targets Ther; 2018; 11():8083-8088. PubMed ID: 30519050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen.
    Liu X; Chen Z; Zhao X; Huang M; Wang C; Peng W; Yin J; Li J; He G; Li X; Zhu X
    Pharmacogenomics; 2015; 16(9):959-70. PubMed ID: 26115082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
    Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
    Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms in
    Zhu X; Liu W; Qiu X; Wang Z; Tan C; Bei C; Qin L; Ren Y; Tan S
    Oncotarget; 2017 Oct; 8(45):80039-80049. PubMed ID: 29108386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy.
    Feng W; Huang M; Zhao X; Chen S; Wang C; Chang J; Guo W; Chen Z; Zhu H; Zhu X
    J Cancer; 2020; 11(11):3310-3317. PubMed ID: 32231736
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].
    Yang J; Wang X; Zou SM; Li HM; Xiao Q; Feng YR; Huang Y; Feng T; Chen JN; Lin DX; Li YX; Jin J; Tan W
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):433-440. PubMed ID: 29936769
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphisms in DNA repair pathway genes and
    Hu X; Qin W; Li S; He M; Wang Y; Guan S; Zhao H; Yao W; Wei M; Liu M; Wu H
    Cancer Manag Res; 2019; 11():285-297. PubMed ID: 30643454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen.
    Liu R; Huang M; Zhao X; Peng W; Sun S; Cao J; Ji D; Wang C; Guo W; Li J; Yin J; Zhu X
    Oncotarget; 2015 Nov; 6(36):39018-27. PubMed ID: 26528696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX.
    Oh SY; Shin A; Kim SG; Hwang JA; Hong SH; Lee YS; Kwon HC
    Oncotarget; 2016 May; 7(21):31204-14. PubMed ID: 27144430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association study of genetic variations in SLCO1B3 gene with prognosis in breast cancer patients treated with neoadjuvant chemotherapy of TA regimen].
    Du ZL; Xu CS; Bian ZM; Peng MT; Li CB; Feng T; Xu XZ; Liu HJ; Zhang BL
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):587-593. PubMed ID: 31434449
    [No Abstract]   [Full Text] [Related]  

  • 15. LRP5 polymorphism-A potential predictor of the clinical outcome in advanced gastric cancer patients treated with EOF regimen.
    Liu X; Huang MZ; Chen ZY; Zhao XY; Wang CC; Peng W; Yin JL; Li J; Zhu XD
    Chin J Cancer Res; 2014 Aug; 26(4):478-85. PubMed ID: 25232223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy.
    Shitara K; Matsuo K; Ito S; Sawaki A; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Muro K
    Asian Pac J Cancer Prev; 2010; 11(2):447-52. PubMed ID: 20843132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRP-1 and KDR polymorphisms are associated with survival time in patients with advanced gastric cancer.
    Zhuo YJ; Shi Y; Wu T
    Oncol Lett; 2019 Nov; 18(5):4629-4638. PubMed ID: 31611971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of
    Wang XQ; Terry PD; Li Y; Zhang Y; Kou WJ; Wang MX
    World J Gastroenterol; 2019 Sep; 25(34):5152-5161. PubMed ID: 31558863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
    Senghore T; Wang WC; Chien HT; Chen YX; Young CK; Huang SF; Yeh CC
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.
    Sawyer MB; Pituskin E; Damaraju S; Bies RR; Vos LJ; Prado CM; Kuzma M; Scarfe AG; Clemons M; Tonkin K; Au HJ; Koski S; Joy AA; Smylie M; King K; Carandang D; Damaraju VL; Hanson J; Cass CE; Mackey JR
    Clin Breast Cancer; 2016 Apr; 16(2):139-44.e1-3. PubMed ID: 26452313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.